Quick guide

Diagnostic approach

  • Focused clinical evaluation, including comprehensive skin examination
  • CBC
  • CMP
  • See “Diagnostics for rash.”

Routine laboratory studies are seldom required for rashes that appear benign, but are necessary in severely ill patients.

Management checklist

  • Don PPE.
  • Isolate patients with fever and petechial rash and use droplet precautions.
  • For life-threatening rash, establish IV and consult dermatology urgently.
  • Supportive care for symptom relief
  • Manage the underlying cause.
  • Admit patients with vital sign abnormalities, systemic infection or syndrome, electrolyte abnormalities, inability to maintain PO intake.

Red flag features

  • Fever
  • Severely ill appearance
  • Hypotension
  • Severe pain
  • Mucosal lesions
  • Extremes of age
  • History of immunosuppression
  • Recently initiated medication

Life-threatening causes

  • Toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • Necrotizing fasciitis
  • Meningococcal septicemia
  • Toxic shock syndrome
  • Disseminated intravascular coagulation
  • Anaphylaxis
  • Rocky Mountain spotted fever
  • DRESS
  • Pemphigus vulgaris

Summary

Rash is a common presenting symptom with many different causes. A systematic approach is necessary to identify life-threatening conditions and reach a definitive diagnosis. Initial management steps include evaluating for red flags for a life-threatening rash and characterizing the rash based on its basic morphology, e.g., petechial or purpuric, erythematous, maculopapular, annular, or vesiculobullous. The cause of rash can often be identified clinically, but specific testing may be required based on the presumptive diagnosis. Management is specific to the condition. Although most rashes can affect individuals of any age, some are more common in childhood (e.g., pediatric viral exanthems).

For details on rashes or lesions due to localized infection, see “Overview of skin and soft tissue infections.”

Etiology

Petechial and purpuric rashes

Febrile or severely ill patients

  • Palpable lesion
    • Meningococcal septicemia
    • Disseminated gonococcal infection
    • Acute bacterial endocarditis
    • Rocky Mountain spotted fever (RMSF)
    • IgA vasculitis
  • Nonpalpable lesion
    • Thrombotic thrombocytopenic purpura (TTP)
    • Purpura fulminans
    • Acute leukemia [3]

Afebrile patients

  • Palpable lesion: vasculitis
  • Nonpalpable lesion: idiopathic thrombocytopenia (ITP)

Erythematous rashes

Febrile or severely ill patients

  • Positive Nikolsky sign
    • Staphylococcal scalded skin syndrome (SSSS)
    • Stevens-Johnson syndrome (SJS)
    • Toxic epidermal necrolysis (TEN)
  • Negative Nikolsky sign
    • Toxic shock syndrome (TSS)
    • Kawasaki disease
    • Scarlet fever

Afebrile patients

  • Positive Nikolsky sign: Toxic epidermal necrolysis
  • Negative Nikolsky sign
    • Anaphylaxis
    • Histamine fish poisoning
    • Medication flushing syndrome, e.g., vancomycin, niacin
    • Alcohol flush reaction

Maculopapular rashes

Febrile or severely ill patients

  • Central distribution
    • Measles
    • Viral exanthem
    • Lyme disease
    • Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)
  • Peripheral distribution
    • Erythema multiforme
    • Meningococcal septicemia
    • RMSF
    • Syphilis
    • Lyme disease

Afebrile patients

  • Central distribution
    • Drug reaction
    • Pityriasis rosea
  • Peripheral distribution
    • Scabies
    • Atopic dermatitis
    • Bed bugs [4]

Vesiculobullous rashes

See “Overview of blistering skin diseases.”

Febrile or severely ill patients

  • Diffuse distribution
    • Varicella
    • Disseminated intravascular coagulation (DIC)
    • Disseminated gonococcal infection
    • Smallpox
  • Localized distribution
    • Necrotizing fasciitis
    • Hand foot and mouth disease

Afebrile patients

  • Diffuse distribution
    • Bullous pemphigoid
    • Pemphigus vulgaris
  • Localized distribution
    • Herpes zoster
    • Contact dermatitis
    • Burns
    • Dyshidrotic eczema

Annular skin lesions [5]

  • Tinea infections
  • Nummular dermatitis
  • Erythema marginatum
  • Erythema multiforme
  • Fixed drug eruption
  • Granuloma annulare
  • Subacute cutaneous lupus erythematosus

Skin plaques and scaling lesions [6]

  • Psoriasis
  • Seborrheic dermatitis
  • Cutaneous lichen planus
  • Pityriasis rubra pilaris
  • Mycosis fungoides
  • Erythroderma
  • Tinea infections
  • See also “Differential diagnosis of scaling.”

Urticaria [7]

See also “Type I hypersensitivity reaction.”

  • Acute (< 6 weeks): viral infection, drug reactions, or food allergens
  • Chronic (≥ 6 weeks)
    • Spontaneous urticaria
    • Chronic inducible urticaria

Childhood rashes [8][9]

See also “Differential diagnosis of infectious rashes in childhood.”

Common causes

  • Roseola infantum
  • Pityriasis rosea
  • Scarlet fever
  • Erythema infectiosum
  • Hand foot and mouth disease
  • Nonbullous impetigo
  • Atopic dermatitis
  • Contact dermatitis
  • Exanthematous cutaneous reaction [10][11]
  • Scabies
  • Tinea infections

Less common causes

  • Varicella zoster (chickenpox)
  • Measles
  • Rubella
  • Erysipelas
  • SSSS
  • SJS/TEN
  • Acute generalized exanthematous pustulosis
  • DRESS
  • RMSF

Initial management

Approach [1][2][12]

  • Don PPE as appropriate, e.g., contact precautions.
  • Isolate patients with fever and petechial rash and escalate PPE to droplet precautions.
  • Identify patients with red flags for a life-threatening rash.
    • Initiate continuous monitoring and place IV access in severely ill patients.
    • Consult dermatology urgently.
  • Initiate treatment for life-threatening causes of rash immediately.
  • Perform a focused clinical evaluation.
  • Narrow the differential diagnosis based on the morphology of the rash (see “Etiology”).
  • Obtain appropriate diagnostic testing.
  • Begin supportive and definitive treatment.

Fever and petechial rash may indicate meningococcal septicemia.

Red flags for a life-threatening rash [2]

  • Fever
  • Severely ill appearance, e.g., lethargy, cyanosis, mottled extremities, hypoventilation or hyperventilation
  • Hypotension
  • Mucosal lesions
  • Severe pain
  • Extremes of age
  • History of immunosuppression
  • Recently initiated medication

Life-threatening causes of rash

  • Pemphigus vulgaris
  • SJS/TEN
  • DRESS
  • TSS
  • Meningococcal septicemia
  • RMSF
  • Necrotizing fasciitis

Disposition [4]

Admit patients with any of the following:

  • Hypotension
  • High fever or hypothermia
  • Systemic infection or underlying condition requiring inpatient management
  • Significant fluid and electrolyte abnormalities
  • Inability to maintain oral intake

Clinical evaluation

The differential diagnosis of a rash can be quickly narrowed using basic morphology and associated clinical findings. [1][2]

Focused history [2][8][12]

Rash characteristics

  • Onset
  • Duration
  • Progression

Associated symptoms

  • Fever
  • Pruritus
  • Pain at rash site
  • Arthralgias

Exposures

  • New medications
  • Recent travel
  • Occupation
  • Change in personal care products
  • Sexual history
  • Sick contacts
  • Recent bites

Focused examination [2][4][12]

General physical examination

  • Overall condition, e.g., mental status and vital signs
  • Lung auscultation
  • Cardiac auscultation
  • Lymphadenopathy

Skin examination

See “Primary skin lesions” and “Secondary skin lesions” for describing and documenting rashes.

  • Rash morphology
    • Petechiae or purpura
    • Erythema
    • Maculopapular rash
    • Vesiculobullous rash
  • Lesion characteristics
    • Palpable or nonpalpable
    • Blanchable
    • Positive or negative Nikolsky sign

Always have the patient disrobe and ensure that the entire body is examined, including mucus membranes and genitalia.

Diagnosis

Laboratory studies [4][12]

Routine laboratory studies are seldom required for rashes that appear benign, but are necessary in severely ill patients.

  • CBC
    • Thrombocytopenia, e.g., in vasculitis
    • Leukocytosis suggests infection or severe inflammatory disease.
  • CMP
    • Electrolyte and acid-base abnormalities suggest severe disease.
    • Abnormal LFTs may indicate hepatitis, e.g., in severe drug reactions.
  • Serology, antibody, and antigen testing
    • Rapid strep test: often positive in scarlet fever
    • EBV serology: positive in infectious mononucleosis
    • Monospot test: positive in infectious mononucleosis, but may be false positive
    • VDRL or FTA-ABS: diagnostic for syphilis
    • Rickettsia antibody panels
    • Lyme antibody testing
    • ANCA: for suspected autoimmune conditions, e.g., eosinophilic granulomatosis with polyangiitis
  • Cultures: CSF for meningococcal septicemia, blood cultures for endocarditis

Dermatologic studies

  • Punch biopsy: for uncertain diagnosis or suspected autoimmune condition
  • Tzanck smear: in vesicular lesions; diagnostic for pemphigus vulgaris, HSV infection, and chickenpox
  • Vesicle or pustule cultures: for suspected bacterial, fungal, or viral infections
  • Patch test: for suspected contact dermatitis, allergic dermatitis
  • KOH prep: for suspected fungal infections

Petechial and purpuric rashes

The lesions of a petechial or purpuric rash do not blanch when pressure is applied.

Common causes of petechial and purpuric rashes [2][3][13]
Images Distinguishing features Diagnostic findings Management
Meningococcal septicemia

  • Palpable rash
  • Fever
  • Symptoms of meningitis [3]
  • Positive CSF and/or blood cultures
  • Immediate stabilization for meningitis, isolation precautions
  • Immediate empiric antibiotics for bacterial meningitis
  • See “Management of meningitis.”
Acute bacterial endocarditis

  • Palpable rash
  • High fever
  • Malaise, fatigue
  • Splinter hemorrhages
  • Janeway lesions
  • Osler nodes
  • Cardiac murmur
  • Valve lesion on echocardiogram
  • Positive blood cultures
  • Empiric antibiotic therapy for infective endocarditis
  • See “Management of infective endocarditis.”
RMSF

  • Palpable rash
  • Fever
  • Headaches
  • Myalgias
  • Clinical diagnosis supported by laboratory studies [14]
  • Immediate empiric antibiotic therapy
  • See “Treatment” in “RMSF.”
Disseminated gonococcal infection

  • Palpable rash
  • Fever
  • Arthralgias
  • Petechiae that progress to pustules
  • Positive culture from blood, urethral, cervix, and/or skin lesion
  • Antibiotic therapy for gonorrhea
  • See “Management of gonorrhea.”
IgA vasculitis

  • Palpable rash
  • Fever
  • Arthralgias
  • Abdominal pain
  • Clinical diagnosis supported by laboratory studies
  • Findings indicating nephritis
  • Fluid therapy
  • Glucocorticoids, IVIg
  • See “Treatment of IgA vasculitis.”
TTP

  • Nonpalpable rash
  • Fever
  • Altered mental status
  • Signs of hemolytic anemia
  • CBC: platelets, hemoglobin
  • Coagulation studies: normal pTT
  • Urinalysis: hematuria, proteinuria
  • Hematology consult
  • Plasma exchange
  • See “Treatment of TTP.”
ITP
  • Nonpalpable rash
  • No fever
  • Mild mucosal or cutaneous bleeding
  • Thrombocytopenia
  • Glucocorticoids, IVIg
  • See “Treatment of ITP.”
Vasculitic syndromes

  • Palpable rash
  • Patients are often afebrile and appear well.
  • Thrombocytopenia
  • ESR and CRP
  • Immunosuppressive therapy
  • See “Vasculitides.”

Unexplained purpura in a child, especially on the trunk, ears, or face, may indicate child abuse. [3]

Diffuse erythematous rashes

Erythematous rashes manifest as diffuse redness that blanches with pressure.

Common causes of erythematous rashes [2][4]
Images Distinguishing features Diagnostic findings Management
SSSS

  • Fever
  • Patient appears severely ill.
  • Tender rash, later bullous
  • Positive Nikolsky sign
  • Leukocytosis
  • Findings of organ failure on CMP
  • Positive blood cultures and/or cultures from the suspected source of infection
  • Fluid therapy
  • Empiric antibiotics
  • See “Management of SSSS.”
TEN and SJS [15]

  • Fever is common.
  • Patient appears severely ill.
  • Mucus membrane involvement
  • Evolves to bullous rash over 5–7 days
  • Positive Nikolsky sign
  • Designation depends on body surface area involvement:
    • < 10%: SJS
    • 10–30%: SJS/TEN
    • > 30%: TEN
  • Leukocytosis
  • Findings of organ failure on CMP
  • Characteristic features on skin biopsy
  • Discontinue offending medications.
  • Initiate burn management.
  • Consider transfer to a burn center.
  • See “Treatment of SJS and TEN.”
TSS

  • Fever
  • Signs of shock
  • Nonexudative mucosal inflammation
  • Negative Nikolsky sign
  • Desquamation occurs after several days.
  • Diagnostic findings of sepsis
  • Immediate hemodynamic support
  • Empiric antibiotic therapy for TSS
  • See “Management of TSS.”
Scarlet fever rash

  • Fever
  • Malaise
  • Sore throat
  • Negative Nikolsky sign
  • Fine papules
  • Positive rapid strep test
  • Throat culture
  • Empiric antibiotics
  • See “Management of scarlet fever.”
Anaphylaxis

  • Features of anaphylaxis
  • No fever
  • Negative Nikolsky sign
  • Clinical diagnosis
  • Elevated serum tryptase
  • IV or IM epinephrine
  • IV fluid resuscitation
  • See “Management of anaphylaxis.”
Histamine fish poisoning [16]

  • History of ingesting dark-meat fish
  • No fever
  • Pruritus and urticaria
  • Burning sensation in mouth
  • Negative Nikolsky sign
  • Clinical diagnosis
  • Antihistamines
  • Epinephrine (if symptoms are severe)
  • See “Histamine fish poisoning.”
Flushing reaction [17][18]

  • Previous exposure to alcohol or a triggering drug, e.g., vancomycin, niacin
  • No fever
  • Negative Nikolsky sign
  • Pruritus
  • Clinical diagnosis
  • Antihistamines
  • Discontinue or slow infusion of triggering medication.

Maculopapular rashes

The mixture of flat and raised discolored areas that define a maculopapular rash may also be the early stage of a petechial, purpuric, or vesiculobullous rash.

Common causes of maculopapular rashes [2][4]
Images Distinguishing features Diagnostic findings Management
Measles

  • Prodrome of fever and malaise
  • “3 Cs”: cough, coryza, and conjunctivitis
  • Blanching rash
  • Koplik spots
  • Positive measles serology and/or PCR
  • Respiratory and contact isolation
  • Supportive therapy
  • Vitamin A supplementation
  • See “Management of measles.”
Kawasaki disease

  • Fever
  • Cervical lymphadenopathy
  • Conjunctival injection
  • Strawberry tongue
  • Peripheral edema
  • Inflammatory markers
  • Variable ECG changes
  • IVIg
  • Aspirin
  • See “Management of Kawasaki disease.”
Secondary syphilis

  • Diffuse reddish-brown or copper lesions on the trunk and extremities
  • Potentially fever and/or malaise
  • Occurs weeks to months after resolution of the initial chancre
  • Positive nontreponemal tests, e.g., RPR, VDRL
  • Positive treponemal tests, e.g., FTA-ABS
  • Antibiotics for syphilis
  • See “Treatment of syphilis.”
Viral exanthem

  • Variable presentation
  • Typically nonpruritic
  • Does not desquamate
  • Typically a clinical diagnosis
  • See “Infectious rashes in childhood.”
Cutaneous drug reactions [10][11]

  • Usually pruritic
  • Begin on the trunk and spread to the extremities
  • Symmetrical distribution
  • Clinical diagnosis
  • Discontinue inciting medication.
  • Antihistamines
Scabies

  • Elongated papules
  • Typically affects interdigital folds, intertriginous areas, and wrists
  • Pruritic
  • Dermoscopic visualization of mites, larvae, ova, or mite feces
  • Scabicidal agents
  • See “Treatment of scabies.”
Atopic dermatitis

  • Dry, scaly rash
  • Infants: cheeks, scalp, extensor areas
  • Children and adults: antecubital fossa, extensor areas
  • Intense pruritus
  • Clinical diagnosis
  • Topical emollients
  • Topical corticosteroids
  • See “Treatment of atopic dermatitis.”
Pityriasis rosea
  • Pityriasis rosea may appear as an annular lesion or in a maculopapular distribution; see “Annular skin lesions.”

Meningococcal septicemia, RMSF, and Stevens-Johnson syndrome are life-threatening conditions that may also cause a maculopapular rash.

Vesiculobullous rashes

Vesiculobullous rashes are composed of multiple fluid-filled lesions caused by a disorder of the epidermal-dermal junction.

Common causes of vesiculobullous rashes [2][4]
Images Distinguishing features Diagnostic findings Management
Varicella

  • Prodrome of fever, malaise, pharyngitis
  • Macules, papules, and vesicles, simultaneously
  • Spares hands and feet
  • Clinical diagnosis
  • Positive PCR
  • Antihistamines
  • Antiviral therapy for VZV infection (only for patients at high risk)
  • See “Treatment for chickenpox.”
Shingles

  • Grouped vesicles with a dermatomal distribution
  • Severely painful
  • Most common in adults 50–70 years of age
  • Clinical diagnosis
  • Positive PCR
  • Respiratory and contact isolation
  • Early and mild: oral antiviral therapy for herpes zoster
  • Severe: IV acyclovir
  • See “Management of shingles.”
Necrotizing fasciitis [19]

  • Fever
  • Patient appears severely ill
  • Erythema of underlying skin
  • Pain out of proportion to findings
  • Diagnostic findings of sepsis
  • Positive tissue and fluid cultures
  • Emergent surgical debridement
  • Empiric antibiotic therapy for skin and soft tissue infections
  • See “Treatment” in “Necrotizing soft tissue infections.”
Hand, foot, and mouth disease [20]

  • Fever
  • Malaise and anorexia
  • Rash primarily on the hands and feet
  • Painful oral ulcers
  • Clinical diagnosis
  • Supportive care for symptom relief
Bullous pemphigoid [21][22]

  • Diffuse large and tense vesicles
  • Pruritic
  • Prodrome of papular or urticarial lesions
  • Negative Nikolsky sign
  • Positive serology, immunofluorescence assay, and/or histopathology
  • Mild: topical corticosteroids
  • Severe: systemic corticosteroids
  • See “Bullous pemphigoid.”
Pemphigus vulgaris [21][22]

  • Small flaccid and superficial bullae
  • Ruptured bullae coalesce into large erosions.
  • Oral lesions are common.
  • Painful but not pruritic
  • Positive Nikolsky sign
  • Positive serology, immunofluorescence assay, and/or histopathology
  • IV fluid resuscitation
  • Wound care similar to burn management
  • Systemic corticosteroids
  • See “Pemphigus vulgaris.”
Bullous impetigo

  • Large thin-walled bullae
  • Thin serous crust after rupture
  • Most commonly affects the trunk and extremities
  • Negative Nikolsky sign
  • Clinical diagnosis
  • Antibiotic therapy
  • See “Management of impetigo.”
Contact dermatitis

  • History of exposure to a possible offending agent
  • Distinct rash borders
  • Pruritic
  • Clinical diagnosis
  • Patch testing (if the diagnosis is uncertain)
  • Mild: topical corticosteroids
  • Severe: systemic corticosteroids
  • See “Contact dermatitis” for details.

See also “Autoimmune blistering diseases” and “Skin and soft tissue infections.”

Disseminated gonococcal infection, acute generalized exanthematous pustulosis, and smallpox may have a vesiculobullous appearance.

Annular skin lesions

Overview of annular skin lesions
Images Etiology Location Characteristics
Erythema migrans

  • Early localized Lyme disease (Borrelia burgdorferi)
  • At the site of the tick bite
  • Slowly expanding red ring around the tick bite with a central clearing
  • Painless
  • Pruritic (rarely)
  • Self-resolving within 3–4 weeks
Tinea corporis

  • Dermatophyte infection (Trichophyton rubrum)
  • Face
  • Arms and legs
  • Trunk
  • Centrifugally expanding round erythematous plaques with a central clearing
  • Raised border with scales
  • Pruritic
Erythema marginatum

  • Acute rheumatic fever
  • Trunk and extremities
  • Spares the face
  • Centrifugally expanding pink or light red rash with a well-defined outer border and a central clearing
  • Painless
  • Nonpruritic
Nummular dermatitis

  • Immunological hypersensitivity reaction due to xerosis and damage to the epidermal lipid barrier
  • Extremities
  • Well-demarcated coin-shaped lesions
  • Severely pruritic
  • Scabbing
Granuloma annulare

  • Idiopathic
  • Localized form (more common): especially palms and soles
  • Generalized form (rare): involves trunk and extremities
  • Palpable ring-shaped plaques that can be red, pink, violet, or skin-colored with a firm border and central clearing
  • Hypopigmented or hyperpigmented in darker skin tones
  • Pruritic
  • Self-resolving within 2 years
Urticaria

  • Cutaneous mast cell activation and degranulation due to:
    • Infection
    • Type I hypersensitivity reaction
    • Pseudoallergic reaction
  • Generalized involvement of the skin
  • Raised, well-demarcated, erythematous plaques (wheals)
  • Round, oval, or serpiginous
  • Pruritic
  • Transient (disappear within 24 hours)
Erythema multiforme (EM)

  • Type IV hypersensitivity reaction to:
    • Infection (most common): e.g., HSV, Mycoplasma pneumonia, fungal
    • Drugs: e.g., barbiturates, phenytoin, NSAIDs, beta-lactam antibiotics, sulfonamides
    • Immunizations: e.g., diphtheria, tetanus, influenza, HBV
  • Symmetrical distribution
  • Backs of hands and feet first
  • May affect the entire body
  • EM minor: no involvement of mucous membranes
  • EM major: mucosal involvement (oral, ocular, genital ulcers)
  • Initially manifest as erythematous macules, then as papules and vesicles, and finally, as target lesions
  • May be asymptomatic or manifest with pruritus and/or painful burning
  • Self-resolving within a month
Fixed drug eruption

  • Hypersensitivity reaction to specific drugs (e.g., antibiotics, NSAIDs, acetaminophen, barbiturates, anticonvulsants)
  • Most commonly involves oral mucosa, trunk, hands, and/or genitals
  • Recurs in the same location on reexposure to the drug
  • Well-defined, round or oval, erythematous lesion that is usually solitary
  • May develop vesicles or blisters
  • Pruritic and/or burning
Pityriasis rosea

  • Idiopathic
  • Viral (HHV 6 and 7)
  • Herald patch: typically on the trunk
  • Secondary eruption: trunk and extremities
  • Herald patch (a few days to a few weeks before generalized rash)
  • Secondary eruption
    • Oval, salmon-colored papules and plaques
    • Scaly collarette
    • Christmas tree appearance (oriented along Langer lines)
  • Both may be pruritic
  • Self-resolving within 6–12 weeks
Discoid lupus

  • Genetic predisposition: HLA-DR2 and HLA-DR3
  • Hormonal factors (hyperestrogenic states)
  • Environmental factors (e.g., tobacco smoking, UV light exposure)
  • Head
  • Face
  • Neck
  • Well-defined, erythematous scaly plaques
  • Evolve into atrophic, disfiguring scars

Mimics

Skin nodules [23][24]

A skin nodule is an elevated cystic or solid lesion > 1 cm in diameter.

  • Sebaceous hyperplasia
  • Epidermal inclusion cysts
  • Dermatofibroma
  • Acrochordon
  • Rheumatoid nodules
  • Nonmelanoma skin cancer
  • Chancre
  • Leprosy

Cutaneous ulcers [25]

Cutaneous ulcers are rounded or irregularly shaped discontinuities in the skin caused by loss of the epidermis and some portion of the dermis.

  • Chronic venous disease
  • Peripheral artery disease
  • Collagen vascular disease
  • Vasculitides
  • Pyoderma gangrenosum
  • Necrobiosis lipoidica
  • Decubitus ulcer

References

  1. Higgins JC, Maher MH, Douglas MS. "Diagnosing Common Benign Skin Tumors". Am Fam Physician. 92(7). :601-7. (2015)
  2. Brinkman D, Roche L, Ullah K, O’Connor TM. "Multiple cutaneous nodules as the presenting sign of small cell lung cancer". BMJ Case Rep. 2013(may22 1). :bcr2013009160-bcr2013009160. (2013)
  3. Panuncialman J, Falanga V. "Unusual Causes of Cutaneous Ulceration". Surg Clin North Am. 90(6). :1161-1180. (2010)
  4. McCollough M. "The Algorithmic Approach to the Unidentified Rash". Springer International Publishing. :215-240. (2018). ISBN: 9783319756226
  5. Santistevan J, Long B, Koyfman A. "Rash Decisions: An Approach to Dangerous Rashes Based on Morphology". J Emerg Med. 52(4). :457-471. (2017)
  6. Thomas AE, Baird SF, Anderson J. "Purpuric and petechial rashes in adults and children: initial assessment". BMJ. :i1285. (2016)
  7. Walls R, Hockberger R, Gausche-Hill M, Erickson TB, Wilcox SR. "Rosen's Emergency Medicine 10th edition- Concepts and Clinical Practice E-Book". Elsevier Health Sciences. (2022). ISBN: 9780323757904
  8. Trayes KP, Savage K, Studdiford JS. "Annular Lesions: Diagnosis and Treatment". Am Fam Physician. 98(5). :283-291. (2018)
  9. Gisondi P, Bellinato F, Girolomoni G. "Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks". J Clin Med. 9(11). :3594. (2020)
  10. Schettini N, Corazza M, Schenetti C, Pacetti L, Borghi A. "Urticaria: A Narrative Overview of Differential Diagnosis". Biomedicines. 11(4). :1096. (2023)
  11. Allmon A, Deane K, Martin KL. "Common Skin Rashes in Children". Am Fam Physician. 92(3). :211-6. (2015)
  12. James G. Dinulos. "What's new with common, uncommon and rare rashes in childhood". Curr Opin Pediatr. 27(2). :261-266. (2015)
  13. Khan DA. "Cutaneous drug reactions". J Allergy Clin Immunol. 130(5). :1225-1225.e6. (2012)
  14. Segal AR, Doherty KM, Leggott J, Zlotoff B. "Cutaneous Reactions to Drugs in Children". Pediatrics. 120(4). :e1082-e1096. (2007)
  15. Ely JW, Seabury Stone M. "The generalized rash: part II. Diagnostic approach". Am Fam Physician. 81(6). :735-9. (2010)
  16. Antonov D, Kamarashev J, Kazandjieva J, Neykova T, Tsankov N. "The rash that becomes purpuric, petechial, hemorrhagic, or ecchymotic". Clin Dermatol. 38(1). :3-18. (2020)
  17. Hussain A, Gray C, Marlowe S, et al. "Unconventional Rocky Mountain Spotted Fever Presentation From Kentucky: A Compelling Case Report and Literature Review". Cureus. (2023)
  18. Zimmerman D, Dang NH. "Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)". Springer International Publishing. :267-280. (2019). ISBN: 9783319745879
  19. Feng C, Teuber S, Gershwin ME. "Histamine (Scombroid) Fish Poisoning: a Comprehensive Review". Clin Rev Allergy Immunol. 50(1). :64-69. (2015)
  20. Shrivastava S, Shrivastava S. "Vancomycin Flushing Syndrome: A Case Report". Cureus. (2024)
  21. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. "The Alcohol Flushing Response: An Unrecognized Risk Factor for Esophageal Cancer from Alcohol Consumption". PLoS Med. 6(3). :e1000050. (2009)
  22. Fatimah L, Kiat H, En Natalie Y. "Necrotizing fasciitis: How reliable are the cutaneous signs?". J Emerg Trauma Shock. 10(4). :205. (2017)
  23. Saguil A, Kane SF, Lauters R, Mercado MG. "Hand-Foot-and-Mouth Disease: Rapid Evidence Review". Am Fam Physician. 100(7). :408-414. (2019)
  24. Meijer JM, Diercks GFH, de Lang EWG, Pas HH, Jonkman MF. "Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid". JAMA Dermatol. 155(2). :158. (2019)
  25. Di Lernia V, Casanova DM, Goldust M, Ricci C. "Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment". Dermatol Pract Concept. :e2020050. (2020)